Docket Number: 14A-870108
Inventor:Shu-Mei Liang、Jeng-Hwan Wang
IP Status:know how
Abstract:
The outbreak of Foot-and-mouth disease (FMD) in Taiwan in 1997 resulted in huge economic loss. Recently, the global FMD epidemic has made this disease the number one enemy in farming industry.
Our laboratory has been engaged in the development of FMD vaccine in the past few years. We have developed not only DNA vaccine but also recombinant subunit vaccine against FMD. These vaccine candidates not only produced high titers of antibodies in mice but also protected swine from FMD virus challenge.
Fields of Application:
- Biotechnology.
- Vaccine.
- Diagnostic kit.
- Research reagents
Advantages when compared to the existing technologies:
- The recombinant VP1 will provide a good reagent for developing diagnostics kits for FMD.
- The protein will serve as a research tool for biochemical and biophysical studies of FMDV as well as vaccine components against FMDV.
- This invention provides an alternative FMD vaccine to obviate the need to produce the quantities of virus that are needed for the production of conventional inactivated vaccines, and to eliminate entirely the need to use virus in the vaccines.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you
